JWCA
VRTX icon

J.W. Cole Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

J.W. Cole Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$702K Sell
1,414
-151
-10% -$66.9K 0.01% 878
2026
Q1 		$699K Buy
1,565
+242
+18% +$113K 0.02% 454
2025
Q4 		$559K Sell
1,323
-164
-11% -$70.7K 0.01% 846
2025
Q3 		$582K Sell
1,487
-97
-6% -$40.5K 0.01% 934
2025
Q2 		$705K Sell
1,584
-169
-10% -$77.9K 0.02% 801
2025
Q1 		$850K Buy
1,753
+1,044
+147% +$487K 0.03% 589
2024
Q4 		$286K Buy
709
+20
+3% +$9.27K 0.01% 799
2024
Q3 		$320K Sell
689
-156
-18% -$74.9K 0.01% 748
2024
Q2 		$396K Buy
845
+63
+8% +$27.3K 0.02% 600
2024
Q1 		$327K Buy
782
+195
+33% +$82.4K 0.02% 661
2023
Q4 		$239K Buy
+587
New +$217K 0.01% 711
2022
Q1 		– Sell
-1,402
Closed -$308K – 874
2021
Q4 		$308K Sell
1,402
-187
-12% -$36.4K 0.02% 642
2021
Q3 		$288K Buy
1,589
+163
+11% +$31.8K 0.02% 367
2021
Q2 		$288K Buy
1,426
+376
+36% +$78.6K 0.02% 591
2021
Q1 		$226K Buy
+1,050
New +$231K 0.02% 596

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

J.W. Cole Advisors's VRTX Position: Q2 2026 in Review

J.W. Cole Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 9.6% in Q2 2026, selling an estimated $66.9K and leaving 1,414 shares worth $702K. The position accounts for 0.01% of the portfolio, ranked #878.

J.W. Cole Advisors first reported a position in VRTX in Q1 2021 and has held it in 15 quarters since. The position peaked at $850K in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • J.W. Cole Advisors held 1,414 shares of Vertex Pharmaceuticals worth $702K as of Q2 2026.
  • J.W. Cole Advisors sold 151 Vertex Pharmaceuticals shares in Q2 2026, an estimated $66.9K.
  • Vertex Pharmaceuticals made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #878 holding.
  • J.W. Cole Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 15 quarters since.
  • J.W. Cole Advisors's Vertex Pharmaceuticals position peaked at $850K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.